Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...
Australia’s access to affordable medicines could be under threat from global tensions, with one woman forced to fork out $220 ...
Key Points Interested in Oculis Holding AG? Here are five stocks we like better. Oculis' Phase 3 DIAMOND trials of OCS-01 in ...
On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological ...
The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial ...
Vision problems are often dismissed as simple eye strain, fatigue, or the need for a new pair of glasses. But in some cases, sudden blurred vision, pain behind the eyes, or difficulty seeing colours ...
More than 51,000 people over State Pension age are receivingAttendance Allowance for visual disorders, according to the ...
Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME ...
Low-cost, hard to track, harder to stop and capable of overwhelming in swarms, the fibre-optic-guided drones are proving to be a disruptive force in the Russia-Ukraine conflict and parts of the West ...
Hezbollah's cheap fibre-optic drones are creating new challenges for Israeli troops in southern Lebanon, forcing the military to adapt its tactics against an increasingly lethal threat. The Israeli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results